Alzheimer’s News

• May 2, 2019

  Bob Mackie Receives Geoffrey Beene Lifetime Achievement Award

  Think Bob Mackie, and chances are you will remember that amazing moment Cher stepped on the 1986 Oscars red carpet in a naked-yet-dressed look replete with a raven-black feather headpiece for the ages (and ageless).

  Read more
• May 2, 2019

  Bob Mackie Will Receive the Geoffrey Beene Lifetime Achievement Award From the CFDA

  With the announcement that Bob Mackie will receive the Geoffrey Beene Lifetime Achievement honor this year, the bar for this CFDA Award has just been raised.

  Read more
• January 28, 2019

  Study Offers Hint of Hope for Saving Office Dementia in Some People

  ...

  Read more
• January 24, 2019

  John Mendelshon

  ...

  Read more
• December 18, 2018

  Is Aerobic Exercise the Key to Successful Aging?

  Aerobic activities like jogging and interval training can make our cells biologically younger; weight training did not have the same effect.

  Read more
• December 17, 2018

  The Brain Fog of Menopause

  ‘Menopause-related cognitive impairment happens to women in their 40s and 50s, women in the prime of life who suddenly have the rug pulled out from under them,’ an expert says.

  Read more
• December 14, 2018

  Is Eating Deli Meats Really That Bad for You?

  Even small amounts of processed meat increase the risk of colorectal cancer.

  Read more
• April 29, 2018

  CRISPR: The gene-editing tool revolutionizing biomedical research

  A new tool could be the key to treating genetic diseases and may be the most consequential discovery in biomedicine this century

  Read more
• July 25, 2017

  Overwhelming Majority Of Americans Say Discussions About Clinical Trials Should Be A Part Of Standard Of Care

  An overwhelming majority of Americans (86%) agree that health care professionals should discuss clinical trials with patients diagnosed with a disease as part of their standard of care, according to a new national public opinion survey commissioned by Research!America.

  Read more
• June 20, 2017

  Gene variant protecting against Alzheimer’s disease decreases plasma beta-amyloid levels

  The APP gene variant protecting against Alzheimer’s disease significantly decreases plasma beta-amyloid levels in a population cohort. This is a very significant discovery, as many on-going drug trials in the field of Alzheimer's disease focus on decreasing beta-amyloid levels in the brain tissue. According to the study, a 30% life-long decrease in beta-amyloid levels is not associated with detrimental effects on lipid or glucose metabolism, or on any other metabolic factors.

  Read more
• January 12, 2017

  Researchers find a potential target for anti-Alzheimer treatments

  The USP9 gene has an indirect influence on the so-called tau protein, which is believed to play a significant role in the onset of Alzheimer’s disease.

  Read more
• July 26, 2016

  Health-eBrain study offers Alzheimer’s caregivers a “mobile mirror” of their own cognitive vitality

  A study focused on the impact that caring for an individual with Alzheimer's has on the caregiver's own brain and behavioral health has now moved into Phase II. This next phase of the Health-eBrain Study, done in collaboration with BrightFocus Foundation, Geoffrey Beene Foundation Alzheimer’s Intitiative, AnthroTronix and Mindoula, will be announced at the Global Alliance for Women’s Brain Health during the Alzheimer’s Association International Conference today in Toronto.

  Read more
• October 12, 2014

  Breakthrough Replicates Human Brain Cells for Use in Alzheimer’s Research

  For the first time, and to the astonishment of many of their colleagues, researchers created what they call Alzheimer’s in a Dish — a petri dish with human brain cells that develop the telltale structures of Alzheimer’s disease.

  Read more
• May 5, 2014

  Deaths from Alzheimer’s more than reported, study says

  USA Today (March 5, 2014): Alzheimer's disease accounts for many more deaths than we've realized, a new study concludes, making it nearly as lethal as the nation's two biggest killers, heart disease and cancer.

  Read more
• November 8, 2013

  FNIH, Geoffrey Beene Foundation Name Winner of Alzheimer’s Challenge

  GEN News (November 8, 2013): To advance the study of male/female differences in Alzheimer's disease (AD), the organizers of a neurodiscovery challenge have announced the winner of the $50,000 grand prize. The organizers-the Foundation for the National Institutes of Health (FNIH) and the Geoffrey Beene Foundation-had narrowed the field of potential winners to just three. Ultimately, in a voting process that included public participation, the winner emerged: Enrico Glaab, Ph.D., a research associate at the Luxembourg Centre for Systems Biomedicine, University of Luxembourg.

  Read more
• October 29, 2013

  FNIH And Geoffrey Beene Foundation Alzheimer’s Initiative Open Online Voting To The Public For The 2013 Geoffrey Beene Global NeuroDiscovery Challenge

  Bethesda, MD (October 29, 2013): The Foundation for the National Institutes of Health, in association with the Geoffrey Beene Foundation Alzheimer’s Initiative, today announced the top four winners of the preliminary round of the first-ever cha...

  Read more
• April 30, 2013

  Geoffrey Beene Foundation Alzheimer’s Initiative Announces $100,000 Innovation Challenge

  Washington, DC (April 30, 2013): The Geoffrey Beene Foundation Alzheimer’s Initiative last night launched the 2013 Geoffrey Beene Global NeuroDiscovery Challenge at the April 29 Society for Women’s Health Research Gala at the Mandarin Hot...

  Read more
• June 1, 2012

  Turning the Light on Alzheimer’s PET-CT Solution Ushers in Brighter Future for Patients and Caregivers

  Imaging Life: Cognitive decline and the many forms of dementia affect almost every community across the globe, and according to the World Health Organization (WHO), of the 35.6 million people currently diagnosed with dementia, the vast majority have ...

  Read more
• February 29, 2012

  Reinvention: Caring for Loved Ones with Alzheimer’s

  MORE: In the early 1990s, Meryl Comer and Harvey Gralnick lived the life of Washington, D.C., glitterati. Comer anchored the television show It’s Your Business, a nationally syndicated debate program. Gralnick, a doctor, headed hematology and ...

  Read more
• February 1, 2012

  Path Is Found for the Spread of Alzheimer’s

  The New York Times: Alzheimer’s disease seems to spread like an infection from brain cell to brain cell, two new studies in mice have found. But instead of viruses or bacteria, what is being spread is a distorted protein known as tau. ...

  Read more
• December 15, 2010

  Would You Want to Know If You’re at Risk for Alzheimer’s?

  Big Think: Genetic testing is advancing rapidly, and we can now find out our risk factor for developing Alzheimer's. But without a cure or treatment available, what's the point?

  Read more
• December 3, 2010

  Michael Weiner, MD, named “Rock Star of Science”

  Scientific Data Sharing Project: Michael Weiner, MD, Director of the Center for Imaging of Neurodegenerative Diseases (CIND) at the San Francisco VA Medical Center, is among a prestigious group of 17 scientists named 2010 Rock Stars of Science by the Geoffrey Beene Foundation.

  Read more
• November 17, 2010

  Stanford Neurologist Rocks Out for Science

  Scope Blog: It's not every day that a Stanford physician gets to spend several hours on set with a rock star.

  Read more
• November 16, 2010

  Why It’s Time to Rock Alzheimer’s

  Huffington Post: Tomorrow, a glitzy 6 page public service campaign goes public in GQ magazine, featuring a band of 19 leading biomedical research scientists paired up with 8 famous rock stars. ...

  Read more
• September 25, 2009

  Prevention and cure of Alzheimer’s disease important to Americans

  News-Medical.Net: A new voter survey sponsored by the ACT-AD Coalition (Accelerate Cure/Treatments for Alzheimer's Disease) finds that three-quarters of Americans nationwide and across party lines say it is personally important to them to find a cure or to prevent Alzheimer's disease, while a similar proportion of the national electorate say they look to Congress to make it "a national priority" to speed up the Food and Drug Administration's (FDA) review process in specific ways for therapies that slow, halt or reverse the disease.

  Read more
• May 29, 2009

  Dude looks like a … scientist?

  Boston.com: Noted Alzheimer's disease researcher Rudolph Tanzi, known for unraveling genetic clues to the devastating disorder in his lab at Massachusetts General Hospital, shows his hipper, rock-and-roll side in a magazine spread promoting science.

  Read more
• May 11, 2009

  The Alzheimer’s Project

  Geoffrey Beene Gives Back® Alzheimer’s Initiative is a marquee sponcsor of HBO’s “The Alzheimer’s Project.” ...

  Read more
• April 28, 2009

  Geoffrey Beene Gives Back® Alzheimer’s Initiative Co-Sponsors Pioneering New HBO Alzheimer’s Project

  GeoffreyBeene.com: Designer menswear brand’s unique retail-driven philanthropy backs HBO’s efforts to reveal the hidden truth and reason for hope behind America’s next health crisis. ...

  Read more
• April 17, 2009

  20-year Study Determines How Personal Genomics Affects Behavior

  Esther Landhuis: With initiative and a few bucks, consumers nowadays can send tubes of saliva to a company that will analyze their DNA and offer personalized risk assessments for a host of common conditions including diabetes, heart attack, and Alzhe...

  Read more
• March 26, 2009

  Video: ABC Nightline Report on Alzheimer’s Disease (Part 2)

  Read more
• March 26, 2009

  Video: ABC Nightline Report on Alzheimer’s Disease (Part 1)

  Read more
• January 1, 2009

  French lessons: Leadership in Alzheimer’s disease

  The Alzheimer’s Association: Published by Meryl Comer, President of the Geoffrey Beene Gives Back® Alzheimer’s Initiative. ...

  Read more
• October 1, 2008

  Early Alzheimer’s disease diagnostics: Wait! Wait! Don’t tell me!

  Published by Meryl Comer, President of the Geoffrey Beene Gives Back® Alzheimer’s Initiative. ...

  Read more
• July 8, 2008

  The “tipping point” in the Alzheimer’s dialogue: It’s all about the messenger

  Published by Meryl Comer, President of the Geoffrey Beene Gives Back® Alzheimer’s Initiative. ...

  Read more
• July 1, 2008

  National Leaders to Discuss Challenges in Diagnosing Early-Stage Alzheimer Disease

  The Alzheimer Research Forum, the Web’s foremost community of AD researchers, in collaboration with the Geoffrey Beene Gives Back® Alzheimer’s Initiative and Alzheimer Study Group, has assembled a panel of thought leaders to address the ...

  Read more
• December 6, 2007

  Alzheimer’s Researcher and Geoffrey Beene Foundation Exec Honored with the 2007 Senator Proxmire Award

  Dale B. Schenk, Ph.D, Executive Vice President and Chief Scientific Officer for Elan Pharmaceuticals, Inc., a celebrated scientist who has made fundamental breakthroughs in basic and clinical Alzheimer’s research over the past twenty years, and...

  Read more
• November 29, 2007

  Members of Bipartisan Alzheimer’s Study Group Announced; Political and Community Leaders Underscore Strong Support

  WASHINGTON, DC – Today former Speaker of the House Newt Gingrich and former U.S. Senator Bob Kerrey, co-chairs of the Alzheimer’s Study Group (ASG), announced the full membership of the taskforce they have assembled to develop and advance str...

  Read more
• February 22, 2006

  From the bedside: “A terrified witness to the future.”

  Published by Meryl Comer, President of the Geoffrey Beene Gives Back® Alzheimer’s Initiative. ...

  Read more